Methacrylic Acid

Methacrylic Acid

SCHEMBL173936

C=C(C)C(=O)O.C=CCOCC=C

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
CA7 P43166 1/20 0.34
TSHR P16473 2/20 0.34
ALDH1A1 P00352 3/20 0.33
THRB P10828 1/20 0.33
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CA9 Q16790 1/20 0.31
MAPT P10636 1/20 0.31
CACNA1B Q00975 1/20 0.31
APBA1 Q02410 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL27716215 1.00 TDP1 (0.35) TDP1CA1CA2MEN1POLB
Methacrylic Acid SCHEMBL28213805 1.00 TDP1 (0.35) TDP1CA1CA2MEN1POLB
Methacrylic Acid SCHEMBL11113770 0.96 MEN1 (0.36) TDP1CA1CA2MEN1POLB
Methacrylic Acid SCHEMBL29155230 0.88 ALDH1A1 (0.36) TDP1ALDH1A1CYP3A4
Methacrylic Acid SCHEMBL28127362 0.88 ALOX15 (0.38) TDP1ALDH1A1ALOX15HSD17B10
Acetic Acid SCHEMBL131569 0.87 FFAR3 (0.39) TDP1CA1CA2MEN1POLB
Acetic Acid SCHEMBL27627871 0.87 FFAR3 (0.39) TDP1CA1CA2MEN1POLB
Methacrylic Acid SCHEMBL6338033 0.87 CA1 (0.39) TDP1CA1CA2CA7ALDH1A1
Methacrylic Acid SCHEMBL5050934 0.87 TDP1 (0.36) TDP1CA1CA2CA7TSHR
Methacrylic Acid SCHEMBL1862660 0.87 CA1 (0.39) TDP1CA1CA2CA7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3380537-B1 FLUOROPOLYMER COMPOSITIONS WITH IMPROVED MECHANICAL DAMPENING ARKEMA INC (US) 2025-12-24 EP claimed
EP-3985060-B1 PROCESS FOR MAKING CROSSLINKED CABLE INSULATION USING HIGH MELT STRENGTH ETHYLENE-BASED POLYMER MADE IN A TUBULAR REACTOR AND OPTIONALLY MODIFIED WITH A BRANCHING AGENT DOW GLOBAL TECHNOLOGIES LLC (US) 2025-07-16 EP claimed
EP-4578903-A2 PROCESS FOR MAKING CROSSLINKED CABLE INSULATION USING HIGH MELT STRENGTH ETHYLENE-BASED POLYMER MADE IN A TUBULAR REACTOR AND OPTIONALLY MODIFIED WITH A BRANCHING AGENT Dow Global Technologies Llc (US) 2025-07-02 EP claimed
US-RE50063-E1 Fluoropolymer compositions with improved mechanical dampening ARKEMA INC. (US) 2024-07-30 US claimed
CN-117510738-A Impact modifier for resin and preparation method thereof 山东金昌树新材料股份有限公司 2024-02-06 CN claimed
CN-117402300-A Organosilicon-containing impact modifier for resin and preparation method thereof 山东金昌树新材料股份有限公司 2024-01-16 CN claimed
CN-117384324-A Anti-whitening modifier for resin and preparation method thereof 山东金昌树新材料股份有限公司 2024-01-12 CN claimed
WO-2023105177-A1 TWO-COMPONENT ACRYLIC COMPOSITIONS FOR FORMULATING ROAD MARKING PRODUCTS ARKEMA FRANCE (FR) 2023-06-15 WO claimed
US-11674028-B2 Process for making crosslinked cable insulation using high melt strength ethylene-based polymer made in a tubular reactor and optionally modified with a branching agent DOW GLOBAL TECHNOLOGIES LLC (US) 2023-06-13 US claimed
CN-114622406-A Piezoresistive yarn preparation method and piezoresistive yarn prepared by piezoresistive yarn preparation method 佛山(华南)新材料研究院 2022-06-14 CN claimed
CN-101507691-B Oil-in-water emulsified milky skin cosmetic preparation SHISEDO CO LTD 2013-11-13 CN claimed
CN-103146280-A Water-soluble antirust nano composite coating and preparation method thereof UNIV QINGDAO SCIENCE & TECHNOLOGY 2013-06-12 CN claimed
CN-103059681-A Water-based quick-drying externally-crosslinked functional paint and preparation method thereof UNIV QINGDAO SCIENCE & TECHNOLOGY 2013-04-24 CN claimed
US-20120196249-A1 DENTAL TEMPORARY SUPERSTRUCTURES AND MATERIALS FOR PRODUCTION THEREOF AND CORRESPONDING METHODS VOCO GMBH (DE) 2012-08-02 US claimed
US-8182828-B2 Oil-in-water emulsified milky skin cosmetic preparation SHISEIDO COMPANY LTD. (JP) 2012-05-22 US claimed
US-20100168338-A1 METHOD FOR PREPARING A POLYMERIC MATERIAL INCLUDING A MULTIBLOCK COPOLYMER PREPARED BY CONTROLLED FREE-RADICAL POLYMERISATION ARKEMA FRANCE (FR) 2010-07-01 US claimed
CN-101507691-A Oil-in-water emulsified milky skin cosmetic preparation SHISEIDO CO LTD (JP) 2009-08-19 CN claimed
US-20090202600-A1 Oil-In-Water Emulsified Milky Skin Cosmetic Preparation SHISEIDO COMPANY LTD. (JP) 2009-08-13 US claimed
US-20080274074-A1 Method for Controlled Free Radical Polymerization or Copolymerization of Methacrylic and/or Methacrylate Monomers or Exclusively Methacrylic and/or Methacrylate Copolymers ARKEMA FRANCE (FR) 2008-11-06 US claimed
EP-1958610-A2 Method of permanently deforming keratinous fibres including an application step involving an oxidising composition containing a cationic thickening polymer L'Oreal (FR) 2008-08-20 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090202600-A1 Oil-In-Water Emulsified Milky Skin Cosmetic Preparation CUTA, ACMSD, MC1R TDP1 4728/4885CA1 3738/4885CA2 2588/4885
US-20080274074-A1 Method for Controlled Free Radical Polymerization or Copolymerization of Methacrylic and/or Methacrylate Monomers or Exclusively Methacrylic and/or Methacrylate Copolymers PRMT9, MMAB, PRMT8 TDP1 3573/4885CA1 898/4885CA2 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.